NCT00433069View on ClinicalTrials.gov

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions
Chronic Hepatitis C
Interventions
DRUG

Pioglitazone

Increase early virological response to pegylated interferon alpha plus ribavirin by increasing insulin sensitivity

DRUG

Interferon Alfa-2a

Standard of care for chronic hepatitis C

DRUG

Ribavirin

Standard of care for chronic hepatitis C

Trial Locations (1)

1211

Service de Gastroentérologie et d'Hépatologie, University Hospital, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT00433069 - Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone | Biotech Hunter | Biotech Hunter